辅助化疗与为尾骨肉瘤进行截肢的小品种狗的延长生存时间有关
Stefano Zanardi1, Silvia Sabattini1, Federica Rossi2
1Department of Veterinary Medical Sciences, University of Bologna, Ozzano dell'Emilia, Bologna, Italy.
Veterinary and comparative oncology
|January 11, 2025
概括
辅助化疗可以改善附骨肉瘤的小品种狗的生存率. 这项研究表明,化疗对小狗有好处,但需要更多的研究来确认其对转移性传播的有效性.
科学领域:
- 兽医瘤学 兽医瘤学
- 狗癌症研究 狗癌症研究
- 手术瘤学手术瘤学
背景情况:
- 辅助化疗是大品种患有尾骨肉瘤的狗的标准治疗方法.
- 它对小品种狗的益处仍未得到充分研究.
- 骨髓瘤是狗的攻击性骨癌.
研究的目的:
- 为了评估小品种犬 (<15kg) 患有尾骨肉瘤的瘤结果.
- 为了比较只接受手术治疗的狗与手术加辅助化疗治疗的狗之间的结果.
- 评估远程进展时间 (TTDP) 和整体存活时间 (OS).
主要方法:
- 从多个机构的医疗记录的回顾性审查.
- 对43只患有尾骨肉瘤的小品种狗进行分析.
- 基于有或没有辅助化疗的手术治疗结果的结果比较.
主要成果:
- 中位数TTDP为265天,两组之间没有显著差异.
- 平均生存期为270天.
- 接受辅助化疗的狗与单独手术 (150天) 相比,寿命明显长 (353天).
结论:
- 小品种的骨髓瘤与大品种的骨髓瘤一样具有侵略性.
- 辅助化疗可能会延长小品种狗的生存期.
- 进一步的随机试验是必要的,以确认辅助化疗的必要性,以管理转移性疾病在这个人群.
相关概念视频
Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...


